Related Experiment Videos
CSF monoamine metabolites in chronic pain
Randal D France1, Bruno J Urban, Susan Pelton
1Department of Psychiatry, Duke University Medical Center, Durham, NCU.S.A. Department of Anesthesiology, Duke University Medical Center, Durham, NCU.S.A. Laboratory of Behavioral and Neurological Toxicology, National Institute of Environmental Health Services, Durham, NCU.S.A.
Pain
|November 1, 1987
Summary
Chronic pain elevates 5-hydroxyindoleacetic acid (5-HIAA) in female patients, but not males. Depression disrupts the correlation between 5-HIAA and homovanillic acid (HVA) in pain patients.
Area of Science:
- Neuroscience
- Biochemistry
- Pain Medicine
Background:
- Chronic pain affects numerous individuals globally.
- Neurotransmitter imbalances are implicated in chronic pain pathophysiology.
- Cerebrospinal fluid (CSF) analysis offers insights into central nervous system neurotransmitter levels.
Purpose of the Study:
- To investigate CSF levels of specific neurotransmitter metabolites in chronic pain patients.
- To compare these levels with those in healthy controls.
- To explore the influence of comorbid depression on neurotransmitter concentrations and their correlations.
Main Methods:
- CSF samples were collected from 39 chronic pain patients and control subjects.
- Concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3,4-dihydroxyphenylacetic acid (DOPAC) were measured.
- Beta-endorphin levels were also assessed.
- Patients were evaluated for the presence of major depression.
Main Results:
- CSF 5-HIAA levels were significantly increased in female chronic pain patients compared to controls.
- No significant differences in CSF HVA or DOPAC were observed between pain patients and controls.
- Depression did not alter neurotransmitter metabolite concentrations.
- A positive correlation between 5-HIAA and HVA was found in controls and non-depressed pain patients, but this was absent in depressed patients.
Conclusions:
- Elevated CSF 5-HIAA in female chronic pain patients suggests a potential sex-specific neurochemical alteration.
- The findings indicate that major depression may disrupt the relationship between key monoamine metabolites in chronic pain.
- Further research is warranted to elucidate the precise role of these neurotransmitters in chronic pain and depression.